FDA's July update lists 211 newly cleared AI-enabled medical devices, with radiology comprising the majority.
Key Details
- 1211 AI-enabled medical devices cleared by the FDA since September 2024.
- 2About 81% of these updated clearances are radiology software products.
- 3QIH (automated radiological image processing) leads with 58 new clearances.
- 4New de novo authorization for Clairity's Allix5 software which analyzes breast cancer risk from images.
- 5Eight image analyzer products for mammography, ultrasound, and radiographs were reclassified from class III to class II in 2024.
- 6FDA plans to tag devices using foundation models, including LLMs and multimodal AI.
Why It Matters
Radiology continues to be at the forefront of FDA-cleared AI innovation, highlighting the field's rapid adoption of advanced technologies. Monitoring regulatory trends, device reclassifications, and transparency measures is critical for radiology and imaging AI professionals.
Source
AuntMinnie
Related News
•HealthExec
FDA Eases Path for AI in Clinical Decision Support and Healthcare Innovation
FDA publishes new guidance to promote innovation in general wellness and clinical decision support, impacting medical AI including radiology.
•Radiology Business
Patients Favor AI in Imaging Diagnostics, Hesitate on Triage Use
Survey finds most patients support AI in diagnostic imaging but are reluctant about its use in triage decisions.
•Radiology Business
FDA Clears Multi-Disease AI Screening Platform for CT Imaging
HeartLung Corporation's AI-CVD platform receives FDA clearance to detect multiple diseases from a single CT scan.